Skip to content

Tai Chi Mind-Body Therapy for Fibromyalgia

Tai Chi Mind-Body Therapy for Fibromyalgia: a Pilot Single-Blind Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00515008
Enrollment
66
Registered
2007-08-13
Start date
2007-06-30
Completion date
2011-06-30
Last updated
2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Brief summary

The purpose of this study is to obtain preliminary data on the effects of Tai Chi on musculoskeletal pain, fatigue, sleep quality, psychological distress, physical performance,and health status in 60 patients with fibromyalgia.

Detailed description

Fibromyalgia (FM) is a common, complex chronic condition marked by diffuse musculoskeletal pain, fatigue, functional impairment, disability, and psychological distress that affects 6-10 million people in the United States (US). There are currently no satisfactory pharmacological or non-pharmacological treatments for FM. New cost-effective strategies that reduce musculoskeletal pain and improve emotional and physical functioning as well as quality of life in people with FM are urgently needed. Tai Chi is a traditional Chinese discipline with both physical and mental components that appears to benefit a variety of chronic conditions. The physical component provides exercise that is consistent with that recommended for FM (muscle conditioning and aerobic cardiovascular exercise), while the mental component has the potential to improve psychological well-being. These effects are especially pertinent for the treatment of individuals with FM. This is a pilot randomized controlled trial of Tai Chi for fibromyalgia. We plan to enroll 60 patients with fibromyalgia over a two year period. Participants are randomized to either a Tai Chi program or an attention control intervention. Assessments are performed at baseline, week 12 and week 24. This study will provide preliminary data on the potential acceptability and safety of Tai Chi for FM and will help guide the design of a future large-scale study of the efficacy of this alternative therapy.

Interventions

The tai chi intervention took place twice a week for 12 weeks, and each session lasted for 60 minutes. Classes were taught by a tai chi master with more than 20 years of teaching experience. In the first session, he explained the theory behind tai chi and its procedures and provided participants with printed materials on its principles and techniques. In subsequent sessions, participants practiced 10 forms from the classic Yang style of tai chi18 under his instruction. Each session included a warm-up and self-massage, followed by a review of principles, movements, breathing techniques, and relaxation in tai chi. Throughout the intervention period, participants were instructed to practice tai chi at home for at least 20 minutes each day. At the end of the 12-week intervention, participants were encouraged to maintain their tai chi practice, using an instructional DVD, up until the follow-up visit at 24 weeks.

BEHAVIORALControl Intervention

Our wellness education and stretching program similarly included 60-minute sessions held twice a week for 12 weeks.19 At each session, a variety of health professionals provided a 40-minute didactic lesson on a topic relating to fibromyalgia, including the diagnostic criteria; coping strategies and problem-solving techniques; diet and nutrition; sleep disorders and fibromyalgia; pain management, therapies, and medications; physical and mental health; exercise; and wellness and lifestyle management.20 For the final 20 minutes of each class, participants practiced stretching exercises supervised by the research staff. Stretches involved the upper body, trunk, and lower body and were held for 15 to 20 seconds. Participants were instructed to practice stretching at home for 20 minutes a day.

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
American College of Rheumatology Research and Education Foundation
CollaboratorOTHER
Tufts Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 21 or older * Fulfills the American College of Rheumatology (ACR) 1990 diagnostic criteria for FM. (1) a history of widespread musculoskeletal pain on the right and left sides of the body as well as above and below the waist for a minimum duration of 3 months, and (2) pain in 11 or more of 18 specific tender points with moderate or greater tenderness reported upon digital palpation. * Physically able to participate in both the Tai Chi and stretching and education programs according to their primary care physician. * Willing to complete the 12-week study, including twice-a-week Tai Chi or stretching and education sessions

Exclusion criteria

* Prior experience with Tai Chi or other similar types of Complementary and Alternative Medicine in the past 6 months such as Qi gong and yoga since these share some of the principles of Tai Chi * Any health condition limiting the ability to participate as determined by a primary care physician * Any other diagnosed medical condition that is known to contribute to FM symptomatology that is not under adequate control or cannot be expected to remain under adequate control for the study period such as thyroid disease, inflammatory arthritis, scleroderma, systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, myositis and vasculitis or Sjogren's syndrome * Not English-Speaking * Positive pregnancy test or planning pregnancy within the study period * Inability to pass the Mini-Mental Status examination (score below 24) * Enrollment in any other clinical trial within the last 30 days * Plan to permanently relocate from the region during the trial period

Design outcomes

Primary

MeasureTime frameDescription
Mean Change From Baseline of Fibromyalgia Impact Questionnaire Scorewks 12Fibromyalgia Impact Questionnaire (FIQ) is a well-validated, multidimensional measure of the overall severity of fibromyalgia as rated by patients. Categories include the intensity of pain, physical functioning, fatigue, morning tiredness, stiffness, depression, anxiety, job difficulty, and overall well-being.21 The total score ranges from 0 to 100, with higher scores indicating more severe symptoms.

Secondary

MeasureTime frameDescription
Mean Change From Baseline of Patient's Global Assessment Score12 weeksPatients' global assessment score was assessed separately by the participant, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).
Mean Change From Baseline PSQI Score12 weeksThe Pittsburgh Sleep Quality Index (PSQI) is a self-report measure of sleep quality(range, 0 to 21, with higher scores indicating worse sleep quality)
Mean Change From Baseline of 6-Minute Walk Test12 weeks
Mean Change From Baseline of VAS Physicians' Global Assessment of Fibromyalgia SeverityWks 12Physicians' global assessment score was assessed separately by the study physician, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).
Mean Change From Baseline SF-36 Score Mental Component12 weeksThe Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Mental Component is the summary score for the mental quality-of-life components (range, 0 to 100, with higher scores indicating better health status)
Mean Change From Baseline CES-D Score12 weeksThe Center for Epidemiologic Studies (CES-D) Depression Scale (range, 0 to 60, with higher scores indicating more severe depression), is a self-report measure of depressive symptoms.
Mean Change From Baseline CPSS Score12 weeksThe Chronic Pain Self-Efficacy Scale (CPSS) is a self-report score measuring self-efficacy with respect to chronic pain (range, 1 to 10, with higher scores indicating greater self-efficacy).
Mean Change From Baseline SF-36 Score Physical Component12 weeksThe Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Physical Component is the summary score for the physical quality-of-life components (range, 0 to 100, with higher scores indicating better health status)

Countries

United States

Participant flow

Recruitment details

We conducted the trial from July 2007 through May 2009 at Tufts Medical Center, a tertiary care academic hospital in Boston.

Pre-assignment details

90 Underwent baseline evaluation. 24 Were excluded: 1 Did not have fibromyalgia 4 Were physically unable to participate 17 Had scheduling conflicts 1 Was currently practicing tai chi 1 Had preexisting medical condition

Participants by arm

ArmCount
Tai Chi Group
12-week Tai Chi Program.: 12-week Tai Chi classes
33
Control Group
12-week Stretching and Wellness Education Program: Non-TC informational program
33
Total66

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeclined03
Overall StudyLeft the Boston Area11
Overall StudyLost to Follow-up10
Overall StudyScheduling conflict10

Baseline characteristics

CharacteristicTai Chi GroupTotalControl Group
6-Minute walk test522.1 yards
STANDARD_DEVIATION 102.7
511.7 yards
STANDARD_DEVIATION 104.7
501.2 yards
STANDARD_DEVIATION 106.6
Age, Continuous49.7 years
STANDARD_DEVIATION 11.8
50 years
STANDARD_DEVIATION 11.2
50.5 years
STANDARD_DEVIATION 10.5
Body-mass index33.9 kg/m^2
STANDARD_DEVIATION 8.9
32.7 kg/m^2
STANDARD_DEVIATION 8.2
31.5 kg/m^2
STANDARD_DEVIATION 7.4
CES-D score22.6 units on a scale
STANDARD_DEVIATION 9.2
25.2 units on a scale
STANDARD_DEVIATION 9.2
27.8 units on a scale
STANDARD_DEVIATION 9.2
CPSS score5.2 units on a scale
STANDARD_DEVIATION 1.9
4.9 units on a scale
STANDARD_DEVIATION 2.1
4.6 units on a scale
STANDARD_DEVIATION 2.2
Duration of fibromyalgia-related pain - yr11.8 years
STANDARD_DEVIATION 6.9
10.9 years
STANDARD_DEVIATION 7.1
10.0 years
STANDARD_DEVIATION 7.2
FIQ score62.9 units on a scale
STANDARD_DEVIATION 15.5
65.5 units on a scale
STANDARD_DEVIATION 13.3
68 units on a scale
STANDARD_DEVIATION 11
High School or Higher Education31 participants61 participants30 participants
Outcome Expectations for Exercise score3.7 units on a scale
STANDARD_DEVIATION 0.8
3.8 units on a scale
STANDARD_DEVIATION 0.8
3.9 units on a scale
STANDARD_DEVIATION 0.7
Patient's global assessment score5.8 units on a scale
STANDARD_DEVIATION 2.3
6.1 units on a scale
STANDARD_DEVIATION 2.1
6.3 units on a scale
STANDARD_DEVIATION 1.8
Physician's global assessment score5.7 units on a scale
STANDARD_DEVIATION 1.9
5.7 units on a scale
STANDARD_DEVIATION 2.2
5.6 units on a scale
STANDARD_DEVIATION 2.4
PSQI score13.9 units on a scale
STANDARD_DEVIATION 3.1
13.7 units on a scale
STANDARD_DEVIATION 3.4
13.5 units on a scale
STANDARD_DEVIATION 3.7
Region of Enrollment
United States
33 participants66 participants33 participants
Sex: Female, Male
Female
28 Participants57 Participants29 Participants
Sex: Female, Male
Male
5 Participants9 Participants4 Participants
SF-36 score- Mental component42.6 units on a scale
STANDARD_DEVIATION 12.2
40.2 units on a scale
STANDARD_DEVIATION 11.4
37.8 units on a scale
STANDARD_DEVIATION 10.5
SF-36 score- Physical component28.5 units on a scale
STANDARD_DEVIATION 8.4
28.3 units on a scale
STANDARD_DEVIATION 8.1
28.0 units on a scale
STANDARD_DEVIATION 7.8
White race20 participants37 participants17 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 330 / 33
serious
Total, serious adverse events
0 / 330 / 33

Outcome results

Primary

Mean Change From Baseline of Fibromyalgia Impact Questionnaire Score

Fibromyalgia Impact Questionnaire (FIQ) is a well-validated, multidimensional measure of the overall severity of fibromyalgia as rated by patients. Categories include the intensity of pain, physical functioning, fatigue, morning tiredness, stiffness, depression, anxiety, job difficulty, and overall well-being.21 The total score ranges from 0 to 100, with higher scores indicating more severe symptoms.

Time frame: wks 12

ArmMeasureValue (MEAN)
Tai ChiMean Change From Baseline of Fibromyalgia Impact Questionnaire Score-27.8 units on a scale
Control GroupMean Change From Baseline of Fibromyalgia Impact Questionnaire Score-9.4 units on a scale
Secondary

Mean Change From Baseline CES-D Score

The Center for Epidemiologic Studies (CES-D) Depression Scale (range, 0 to 60, with higher scores indicating more severe depression), is a self-report measure of depressive symptoms.

Time frame: 12 weeks

ArmMeasureValue (MEAN)
Tai ChiMean Change From Baseline CES-D Score-8.1 units on a scale
Control GroupMean Change From Baseline CES-D Score-2.3 units on a scale
Secondary

Mean Change From Baseline CPSS Score

The Chronic Pain Self-Efficacy Scale (CPSS) is a self-report score measuring self-efficacy with respect to chronic pain (range, 1 to 10, with higher scores indicating greater self-efficacy).

Time frame: 12 weeks

ArmMeasureValue (MEAN)
Tai ChiMean Change From Baseline CPSS Score1.5 units on a scale
Control GroupMean Change From Baseline CPSS Score0.5 units on a scale
Secondary

Mean Change From Baseline of 6-Minute Walk Test

Time frame: 12 weeks

ArmMeasureValue (MEAN)
Tai ChiMean Change From Baseline of 6-Minute Walk Test60.6 yards
Control GroupMean Change From Baseline of 6-Minute Walk Test16.3 yards
Secondary

Mean Change From Baseline of Patient's Global Assessment Score

Patients' global assessment score was assessed separately by the participant, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).

Time frame: 12 weeks

ArmMeasureValue (MEAN)
Tai ChiMean Change From Baseline of Patient's Global Assessment Score-2.5 units on a scale
Control GroupMean Change From Baseline of Patient's Global Assessment Score-0.6 units on a scale
Secondary

Mean Change From Baseline of VAS Physicians' Global Assessment of Fibromyalgia Severity

Physicians' global assessment score was assessed separately by the study physician, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).

Time frame: Wks 12

ArmMeasureValue (MEAN)
Tai ChiMean Change From Baseline of VAS Physicians' Global Assessment of Fibromyalgia Severity-1.0 units on a scale
Control GroupMean Change From Baseline of VAS Physicians' Global Assessment of Fibromyalgia Severity0.02 units on a scale
Secondary

Mean Change From Baseline PSQI Score

The Pittsburgh Sleep Quality Index (PSQI) is a self-report measure of sleep quality(range, 0 to 21, with higher scores indicating worse sleep quality)

Time frame: 12 weeks

ArmMeasureValue (MEAN)
Tai ChiMean Change From Baseline PSQI Score-3.6 units on a scale
Control GroupMean Change From Baseline PSQI Score-0.7 units on a scale
Secondary

Mean Change From Baseline SF-36 Score Mental Component

The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Mental Component is the summary score for the mental quality-of-life components (range, 0 to 100, with higher scores indicating better health status)

Time frame: 12 weeks

ArmMeasureValue (MEAN)
Tai ChiMean Change From Baseline SF-36 Score Mental Component7.7 units on a scale
Control GroupMean Change From Baseline SF-36 Score Mental Component6.1 units on a scale
Secondary

Mean Change From Baseline SF-36 Score Physical Component

The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Physical Component is the summary score for the physical quality-of-life components (range, 0 to 100, with higher scores indicating better health status)

Time frame: 12 weeks

ArmMeasureValue (MEAN)
Tai ChiMean Change From Baseline SF-36 Score Physical Component8.5 units on a scale
Control GroupMean Change From Baseline SF-36 Score Physical Component1.4 units on a scale

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026